6-K - Genmab A/S | StockGist

AI Analysis

AI-generated analysis. Always verify with the original filing.

Genmab A/S disclosed transactions by six managerial employees involving the vesting and acquisition of restricted stock units on April 1, 2026.

1President & CEO Jan van de Winkel acquired 8,525 shares at DKK 1,758.50 per share.

2EVP & CFO Anthony Pagano acquired 4,206 shares at DKK 1,758.50 per share.

3EVP & Chief Medical Officer Tahamtan Ahmadi acquired 5,186 shares at DKK 1,758.50 per share.

4EVP & Chief Development Officer Judith Klimovsky acquired 4,744 shares at DKK 1,758.50 per share.

5EVP & Chief People Officer Christopher Cozic acquired 2,825 shares at DKK 1,758.50 per share.

6EVP & Chief Strategy Officer Martine van Vugt acquired 439 shares at DKK 1,758.50 per share.

Event Type

Securities Issuance

Disclosure

Voluntary

Variant

6-K

6-K

Current Report on Form 6-K

Securities Issuance

Jan van de Winkel

President & Chief Executive Officer

Acquisition

Effective: 2026-04-01